Skip to main content
British Journal of Sports Medicine logoLink to British Journal of Sports Medicine
. 1996 Mar;30(1):69–70. doi: 10.1136/bjsm.30.1.69

Three cases of nalbuphine hydrochloride dependence associated with anabolic steroid use.

A J McBride 1, K Williamson 1, T Petersen 1
PMCID: PMC1332270  PMID: 8665124

Abstract

Three case reports are presented of nalbuphine hydrochloride dependence meeting DSM IIIR and ICD10 criteria for opioid dependence. Nalbuphine hydrochloride is being obtained from illicit sources and used by those using performance enhancing drugs. In some cases this leads to opioid dependence. There is a potential risks of crossover between the misuse of drugs of performance and the misuse of psychoactive drugs by injection. Further research into the dependence potential of nalbuphine and the extent of the crossover between steroid misuse and other psychoactive drug misuse is required. The legal status of nalbuphine should be reviewed in the light of its availability on the black market.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brower K. J., Blow F. C., Young J. P., Hill E. M. Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict. 1991 Jun;86(6):759–768. doi: 10.1111/j.1360-0443.1991.tb03101.x. [DOI] [PubMed] [Google Scholar]
  2. DuRant R. H., Rickert V. I., Ashworth C. S., Newman C., Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med. 1993 Apr 1;328(13):922–926. doi: 10.1056/NEJM199304013281304. [DOI] [PubMed] [Google Scholar]
  3. Jasinski D. R., Mansky P. A. Evaluation of nalbuphine for abuse potential. Clin Pharmacol Ther. 1972 Jan-Feb;13(1):78–90. doi: 10.1002/cpt197213178. [DOI] [PubMed] [Google Scholar]
  4. Larsen C. E., Stiles R. G., Davis S. C., Jr Magnetic resonance imaging of nalbuphine-induced myocutaneous sclerosis. South Med J. 1993 Nov;86(11):1296–1298. doi: 10.1097/00007611-199311000-00027. [DOI] [PubMed] [Google Scholar]
  5. Schmidt W. K., Tam S. W., Shotzberger G. S., Smith D. H., Jr, Clark R., Vernier V. G. Nalbuphine. Drug Alcohol Depend. 1985 Feb;14(3-4):339–362. doi: 10.1016/0376-8716(85)90066-3. [DOI] [PubMed] [Google Scholar]
  6. Williamson K. Creutzfeldt-Jakob disease:another avenue? 1994 Jan 19-Feb 1Br J Hosp Med. 51(1-2):7–8. [PubMed] [Google Scholar]
  7. Yesalis C. E., Kennedy N. J., Kopstein A. N., Bahrke M. S. Anabolic-androgenic steroid use in the United States. JAMA. 1993 Sep 8;270(10):1217–1221. [PubMed] [Google Scholar]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES